Transdermal and/or topical delivery system comprising clobazam
First Claim
Patent Images
1. A Transdermal drug delivery system (TDDS) for administration of clobazam to a patient comprising:
- an active substance area or reservoir comprising a pharmaceutical composition comprisingabout 4% to about 6% Clobazam;
about 20% to about 25% diethylene glycol monoethyl ether;
about 10% to about 12% triacetin;
about 10% to about 25% of a surfactant selected from the group consisting of caprylocaproyl polyoxyl-8 glycerides, polyethylene glycol sorbitan monolaurate, propylene glycol monolaurate, and mixtures thereof;
about 5% to about 6% Lactic Acid;
about 10% to about 15% glycol;
about 20% to about 35% mixture of dimethylsulfoxide and dimethylisosorbide;
about 0.1% to about 5% gelling agent;
about pH 5.0 to about 6.0, wherein the percentage of components are weight to weight of the composition,further wherein the TDDS comprises an impermeable backing layer and a releasing membrane, which is covered by a detachable protective layer,and further wherein the application period of the TDDS is 7 days.
5 Assignments
0 Petitions
Accused Products
Abstract
A Transdermal Drug Delivery System (TDDS) of the reservoir or plaster type for administrating clobazam for the treatment of various types of anxiety and epilepsy, for 1 day, 2 day, 3 day, 4 day, 5 day, 6 day and/or 7-day continuous application.
-
Citations
15 Claims
-
1. A Transdermal drug delivery system (TDDS) for administration of clobazam to a patient comprising:
-
an active substance area or reservoir comprising a pharmaceutical composition comprising about 4% to about 6% Clobazam; about 20% to about 25% diethylene glycol monoethyl ether; about 10% to about 12% triacetin; about 10% to about 25% of a surfactant selected from the group consisting of caprylocaproyl polyoxyl-8 glycerides, polyethylene glycol sorbitan monolaurate, propylene glycol monolaurate, and mixtures thereof; about 5% to about 6% Lactic Acid; about 10% to about 15% glycol; about 20% to about 35% mixture of dimethylsulfoxide and dimethylisosorbide; about 0.1% to about 5% gelling agent; about pH 5.0 to about 6.0, wherein the percentage of components are weight to weight of the composition, further wherein the TDDS comprises an impermeable backing layer and a releasing membrane, which is covered by a detachable protective layer, and further wherein the application period of the TDDS is 7 days. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
-
Specification